Profile data is unavailable for this security.
About the company
TAIKO PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Company is engaged in three business segments. The Pharmaceutical Product segment is engaged in the manufacturing, sales and export of gastrointestinal drugs under the name SEIROGAN, SEIROGAN TOI-A (sugar coated tablet) and PISHUT. The Infection Control segment is engaged in the planning, development and sales of infection control products, which apply proprietary technique regarding chlorine dioxide gas. The Others segment is engaged in the manufacturing and sales of bath liquid, soap and gardening pyroligneous acid.
- Revenue in JPY (TTM)6.49bn
- Net income in JPY-2.33bn
- Incorporated1946
- Employees208.00
- LocationTaiko Pharmaceutical Co Ltd16F, ORIX Hommachi Bldg1-4-1, Nishihon-machiNishi-kuOSAKA-SHI 550-0005JapanJPN
- Phone+81 643911110
- Fax+81 643911199
- Websitehttps://www.seirogan.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solasia Pharma KK | 159.00m | -1.29bn | 10.68bn | 24.00 | -- | 4.98 | -- | 67.20 | -7.36 | -7.36 | 0.9065 | 9.85 | 0.0639 | 0.8549 | 0.5256 | 6,625,000.00 | -51.68 | -48.57 | -59.50 | -58.83 | 31.45 | 71.01 | -808.81 | -300.89 | 3.42 | -61.24 | 0.0219 | -- | -43.50 | 14.18 | 56.36 | -- | -- | -- |
| Symbio Pharmaceuticals Ltd | 3.70bn | -3.42bn | 11.39bn | 109.00 | -- | 1.76 | -- | 3.08 | -81.51 | -81.51 | 87.41 | 140.73 | 0.4494 | 2.89 | 4.74 | 33,903,380.00 | -41.64 | -19.18 | -46.17 | -23.62 | 79.40 | 65.84 | -92.66 | -24.32 | 9.01 | -- | 0.00 | -- | -44.15 | 7.82 | -266.45 | -- | 42.39 | -- |
| ReproCell Inc | 2.49bn | -178.74m | 12.16bn | 96.00 | -- | 1.38 | -- | 4.88 | -2.03 | -2.03 | 28.72 | 93.57 | 0.2826 | 4.76 | 6.63 | 25,940,160.00 | -2.03 | -7.35 | -2.20 | -8.00 | 48.99 | 39.83 | -7.18 | -27.16 | 9.99 | -- | 0.00 | -- | -17.83 | 17.39 | 89.71 | -- | 13.27 | -- |
| RaQualia Pharma Inc | 2.30bn | -673.00m | 12.16bn | 67.00 | -- | 2.15 | -- | 5.29 | -31.12 | -31.12 | 106.28 | 261.02 | 0.2652 | 3.82 | 2.89 | 34,300,980.00 | -7.77 | 2.13 | -8.56 | 2.26 | 84.78 | 88.49 | -29.28 | 5.32 | 3.55 | -- | 0.3972 | 0.00 | -34.85 | 20.62 | -144.74 | -- | 0.0967 | -- |
| Oncolys Biopharma Inc | 31.38m | -1.82bn | 12.85bn | 34.00 | -- | 8.41 | -- | 409.38 | -95.02 | -95.02 | 1.62 | 67.90 | 0.0167 | 0.00 | 0.2245 | 923,058.80 | -97.25 | -45.75 | -116.54 | -51.86 | 0.00 | 60.46 | -5,813.82 | -233.66 | 7.01 | -- | 0.2052 | -- | -93.54 | -17.86 | -68.72 | -- | 28.18 | -- |
| Ohki Healthcare Holdings Co Ltd | 340.31bn | 2.08bn | 13.16bn | 632.00 | 6.17 | 0.4501 | 5.54 | 0.0387 | 151.56 | 151.56 | 24,771.52 | 2,077.28 | 2.54 | 13.31 | 4.54 | 538,470,000.00 | 1.49 | 1.85 | 6.44 | 8.42 | 5.11 | 6.16 | 0.5859 | 0.7178 | 0.8853 | -- | 0.1698 | 13.92 | 9.92 | 5.30 | 1.28 | 1.51 | -5.34 | 5.92 |
| Stella Pharma Corp | 269.49m | -759.81m | 18.45bn | 44.00 | -- | 6.55 | -- | 68.45 | -24.30 | -24.30 | 8.62 | 82.71 | 0.0594 | 0.0517 | 3.98 | 6,124,796.00 | -16.73 | -22.50 | -17.64 | -24.83 | 80.37 | -- | -281.94 | -488.65 | 15.60 | -943.38 | 0.2481 | -- | 17.65 | -- | 1.94 | -- | -5.87 | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.49bn | -2.33bn | 20.31bn | 208.00 | -- | 2.49 | -- | 3.13 | -46.91 | -46.91 | 130.40 | 160.86 | 0.4474 | 1.91 | 3.71 | 31,211,540.00 | -16.07 | -- | -19.68 | -- | 49.37 | -- | -35.92 | -- | 2.95 | -- | 0.2437 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
| Fuso Pharmaceutical Industries Ltd | 56.52bn | 1.53bn | 20.82bn | 1.31k | 12.30 | 0.5052 | 5.52 | 0.3684 | 179.11 | 179.11 | 6,607.60 | 4,361.00 | 0.7454 | 3.08 | 2.35 | 43,245,600.00 | 2.02 | 1.91 | 3.50 | 3.09 | 25.67 | 26.92 | 2.71 | 2.69 | 0.9393 | 36.59 | 0.2767 | 41.10 | 8.61 | 3.76 | -14.21 | 9.02 | 9.13 | -2.64 |
| Astena Holdings Co Ltd | 53.22bn | 2.10bn | 21.07bn | 1.40k | 9.71 | 0.716 | 4.84 | 0.3958 | 52.92 | 52.92 | 1,343.58 | 717.87 | 0.8105 | 3.42 | 2.73 | 37,904,980.00 | 3.18 | 2.49 | 5.77 | 4.44 | 33.18 | 25.33 | 3.93 | 2.32 | 0.889 | -- | 0.3439 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
| CanBas Co Ltd (Parent) | 0.00 | -1.21bn | 23.93bn | 12.00 | -- | 9.85 | -- | -- | -67.63 | -67.63 | 0.00 | 129.88 | 0.00 | -- | -- | -- | -53.54 | -62.25 | -56.62 | -70.91 | -- | -- | -- | -- | 25.09 | -- | -- | -- | -- | -- | 2.77 | -- | -- | -- |
| StemRIM Inc | 0.00 | -2.02bn | 27.56bn | 44.00 | -- | 3.10 | -- | -- | -32.98 | -32.98 | 0.00 | 144.57 | 0.00 | -- | -- | -- | -20.44 | -8.34 | -20.74 | -8.49 | -- | -- | -- | -68.74 | 131.03 | -11,344.72 | -- | -- | -100.00 | -- | -1,301.17 | -- | -4.35 | -- |
| CellSeed Inc | 199.47m | -957.04m | 27.68bn | 35.00 | -- | 12.62 | -- | 138.75 | -30.72 | -30.72 | 6.40 | 63.29 | 0.0892 | 1.65 | 7.91 | 5,699,172.00 | -42.79 | -49.69 | -46.02 | -54.55 | 55.38 | 63.66 | -479.79 | -428.62 | 16.42 | -5,460.76 | 0.0651 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
Data as of Sep 20 2024. Currency figures normalised to Taiko Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
6.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 13 Oct 2023 | 1.25m | 2.47% |
| Nikko Asset Management Co., Ltd.as of 06 Sep 2024 | 657.70k | 1.30% |
| Daiwa Asset Management Co. Ltd.as of 30 Aug 2024 | 628.60k | 1.24% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Sep 2024 | 267.50k | 0.53% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 173.00k | 0.34% |
| BlackRock Japan Co. Ltd.as of 05 Sep 2024 | 79.40k | 0.16% |
| Asset Management One Co., Ltd.as of 05 Sep 2024 | 64.20k | 0.13% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 05 Sep 2024 | 56.10k | 0.11% |
| SSgA Funds Management, Inc.as of 05 Sep 2024 | 34.90k | 0.07% |
| Sumitomo Mitsui DS Asset Management Co., Ltd.as of 05 Sep 2024 | 21.50k | 0.04% |
More ▼
Data from 30 Jun 2024 - 12 Sep 2024Source: FactSet Research Systems Inc.
